MiRNAs and related polymorphisms in rheumatoid arthritis susceptibility

Autoimmunity Reviews

Volumn 11, Issue 9, 2012, Pages 636-641

  Chatzikyriakidou, Anthoula ^a   Voulgari, Paraskevi V ^a   Georgiou, Ioannis ^a   Drosos, Alexandros A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

MicroRNA; Rheumatoid arthritis; Single nucleotide polymorphism

Indexed keywords

MICRORNA; MICRORNA 132; MICRORNA 146A; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 203; MICRORNA 223; MICRORNA 346; MICRORNA 363; MICRORNA 498; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

DISEASE PREDISPOSITION; DNA POLYMORPHISM; EPIGENETICS; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; NUCLEOTIDE SEQUENCE; REVIEW; RHEUMATOID ARTHRITIS; TRANSCRIPTION REGULATION;

ARTHRITIS, RHEUMATOID; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; NUCLEIC ACID CONFORMATION; ORGAN SPECIFICITY; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84861752704     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2011.11.004     Document Type: Review

References (78)

1. Alamanos Y., Drosos A.A. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005, 4:130-136.
2. Alamanos Y., Voulgari P.V., Drosos A.A. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006, 36:182-188.
3. Dieudé P. Rheumatic diseases: environment and genetics. Joint Bone Spine 2009, 76:602-607.
4. Deighton C.M., Walker D.J., Griffiths I.D., Roberts D.F. The contribution of HLA to rheumatoid arthritis. Clin Genet 1989, 36:178-182.
5. Barton A., Worthington J. Genetic susceptibility to rheumatoid arthritis: an emerging picture. Arthritis Rheum 2009, 61:1441-1446.
6. Brooks W.H., Le Dantec C., Pers J.O., Youinou P., Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010, 34:207-219.
7. Maciejewska Rodrigues H., Jüngel A., Gay R.E., Gay S. Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis. Mol Immunol 2009, 47:12-18.
8. Trenkmann M., Brock M., Ospelt C., Gay S. Epigenetics in rheumatoid arthritis. Clin Rev Allergy Immunol 2010, 39:10-19.
9. Klose R.J., Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 2006, 31:89-97.
10. Bird A.P., Wolffe A.P. Methylation-induced repression-belts, braces, and chromatin. Cell 1999, 99:451-454.
11. Kouzarides T. Chromatin modifications and their function. Cell 2007, 128:693-705.
12. Costa F.F. Non-coding RNAs, epigenetics and complexity. Gene 2008, 410:9-17.
13. Sand M., Gambichler T., Sand D., Skrygan M., Altmeyer P., Bechara F.G. MicroRNAs and the skin: tiny players in the body's largest organ. J Dermatol Sci 2009, 53:169-175.
14. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9:102-114.
15. Orom U.A., Nielsen F.C., Lund A.H. MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell 2008, 30:460-471.
16. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A 2007, 104:9667-9672.
17. Zhou X., Duan X., Qian J., Li F. Abundant conserved microRNA target sites in the 5'-untranslated region and coding sequence. Genetica 2009, 137:159-164.
18. Duroux-Richarda I., Jorgensena C., Apparailly F. miRNAs and rheumatoid arthritis - promising novel biomarkers. Swiss Med Wkly 2011, 141:w13175.
19. Wittmann J., Jäck H.M. microRNAs in rheumatoid arthritis: midget RNAs with a giant impact. Ann Rheum Dis 2011, 70(Suppl. 1):i92-i96.
20. Thamilarasan M., Koczan D., Hecker M., Paap B., Zettl U.K. MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun Rev May 18 2011, [Epub ahead of print].
21. Iborra M., Bernuzzi F., Invernizzi P., Danese S. MicroRNAs in autoimmunity and inflammatory bowel disease: Crucial regulators in immune response. Autoimmun Rev Jul 11 2010, [Epub ahead of print].
22. Alevizos I., Illei G.G. MicroRNAs in Sjögren's syndrome as a prototypic autoimmune disease. Autoimmun Rev 2010, 9:618-621.
23. Pauley K.M., Satoh M., Chan A.L., Bubb M.R., Reeves W.H., Chan E.K. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 2008, 10:R101.
24. Nakasa T., Miyaki S., Okubo A., Hashimoto M., Nishida K., Ochi M., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008, 58:1284-1292.
25. Stanczyk J., Pedrioli D.M., Brentano F., Sanchez-Pernaute O., Kolling C., Gay R.E., et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008, 58:1001-1009.
26. Li J., Wan Y., Guo Q., Zou L., Zhang J., Fang Y., et al. Altered micro-RNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis. Arthritis Res Ther 2010, 12:R81.
27. Murata K., Yoshitomi H., Tanida S., Ishikawa M., Nishitani K., Ito H., et al. Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritism. Arthritis Res Ther 2010, 12:R86.
28. Niimoto T., Nakasa T., Ishikawa M., Okuhara A., Izumi B., Deie M., et al. MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord 2010, 11:209.
29. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103:12481-12486.
30. Curtale G., Citarella F., Carissimi C., Goldoni M., Carucci N., Fulci V. D Franceschini, F. Meloni, V. Barnaba, G. Macino, An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115:265-273.
31. Hou J., Wang P., Lin L., Liu X., Ma F., An H., et al. MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183:2150-2158.
32. Jazdzewski K., Murray E.L., Franssila K., Jarzab B., Schoenberg D.R., de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2008, 105:7269-7274.
33. Tang Y., Luo X., Cui H., Ni X., Yuan M., Guo Y., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signalling proteins. Arthritis Rheum 2009, 60:1065-1075.
34. Xu W., Xu J., Liu S., Chen B., Wang X., Li Y., et al. Effects of Common Polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on Cancer Susceptibility: A Meta-Analysis. PLoS One 2011, 6:e20471.
35. Yue C., Wang M., Ding B., Wang W., Fu S., Zhou D., et al. Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol Oncol 2011, 122:33-37.
36. Li D., Wang T., Song X., Qucuo M., Yang B., Zhang J., et al. Genetic study of two single nucleotide polymorphisms within corresponding microRNAs and susceptibility to tuberculosis in a Chinese Tibetan and Han population. Hum Immunol 2011, 72:598-602.
37. Zhou B., Wang K., Wang Y., Xi M., Zhang Z., Song Y., et al. Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog 2011, 50:499-505.
38. Okubo M., Tahara T., Shibata T., Yamashita H., Nakamura M., Yoshioka D., et al. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 2010, 15:524-531.
39. Pastrello C., Polesel J., Della Puppa L., Viel A., Maestro R. Association between hsa-mir-146a genotype and tumor age-of-onset in BRCA1/BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 2010, 31:2124-2126.
40. Guo H., Wang K., Xiong G., Hu H., Wang D., Xu X., et al. A functional varient in microRNA-146a is associated with risk of esophageal squamous cell carcinoma in Chinese Han. Fam Cancer 2010, 9:599-603.
41. Zeng Y., Sun Q.M., Liu N.N., Dong G.H., Chen J., Yang L., et al. Correlation between pre-miR-146a C/G polymorphism and gastric cancer risk in Chinese population. World J Gastroenterol 2010, 16:3578-3583.
42. Xu B., Feng N.H., Li P.C., Tao J., Wu D., Zhang Z.D., et al. A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo. Prostate 2010, 70:467-472.
43. Jazdzewski K., Liyanarachchi S., Swierniak M., Pachucki J., Ringel M.D., Jarzab B., et al. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc Natl Acad Sci U S A 2009, 106:1502-1505.
44. Xu T., Zhu Y., Wei Q.K., Yuan Y., Zhou F., Ge Y.Y., et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis 2008, 29:2126-2131.
45. Shen J., Ambrosone C.B., DiCioccio R.A., Odunsi K., Lele S.B., Zhao H. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis. Carcinogenesis 2008, 29:1963-1966.
46. Chatzikyriakidou A., Voulgari P.V., Georgiou I., Drosos A.A. The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol 2010, 71:382-385.
47. Chatzikyriakidou A., Voulgari P.V., Georgiou I., Drosos A.A. A polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility. Joint Bone Spine 2010, 77:411-413.
48. Lei S.F., Papasian C.J., Deng H.W. Polymorphisms in predicted miRNA binding sites and osteoporosis. J Bone Miner Res 2011, 26:72-78.
49. McCoy C.E., Sheedy F.J., Qualls J.E., Doyle S.L. S.R, P.J. Quinn Murray, L.A. O'Neill, IL-10 inhibits miR-155 induction by Toll-like receptors. J Biol Chem 2010, 285:20492-20498.
50. Kurowska-Stolarska M., Alivernini S., Ballantine L.E., Asquith D.L., Millar N.L., Gilchrist D.S., et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci U S A 2011.
51. Ceolotto G., Papparella I., Bortoluzzi A., Strapazzon G., Ragazzo F., Bratti P., et al. Interplay between miR-155, AT1R A1166C polymorphism, and AT1R expression in young untreated hypertensives. Am J Hypertens 2011, 24:241-246.
52. Martin M.M., Buckenberger J.A., Jiang J., Malana G.E., Nuovo G.J., Chotani M., et al. The human angiotensin II type 1 receptor + 1166 A/C polymorphism attenuates microRNA-155 binding. J Biol Chem 2007, 282:24262-24269.
53. Sethupathy P., Borel C., Gagnebin M., Grant G.R., Deutsch S., Elton T.S., et al. Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: A mechanism for functional single-nucleotide polymorphisms related to phenotypes. AJHG 2007, 81:405-413.
54. Nakamachi Y., Kawano S., Takenokuchi M., Nishimura K., Sakai Y., Chin T., et al. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 2009, 60:1294-1304.
55. Lindenblatt C., Schulze-Osthoff K., Totzke G. IkappaBzeta expression is regulated by miR-124a. Cell Cycle 2009, 8:2019-2023.
56. Stanczyk J., Ospelt C., Karouzakis E., Filer A., Raza K., Kolling C., et al. Altered expression of miR-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 2011, 63:373-381.
57. Fulci V., Scappucci G., Sebastiani G.D., Giannitti C., Franceschini D., Meloni F., et al. miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis. Hum Immunol 2010, 71:206-211.
58. Pulikkan J.A., Dengler V., Peramangalam P.S., Peer Zada A.A., Müller-Tidow C., Bohlander S.K., et al. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115:1768-1778.
59. Lu H., Buchan R.J., Cook S.A. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovasc Res 2010, 86:410-420.
60. Alsaleh G., Suffert G., Semaan N., Juncker T., Frenzel L., Gottenberg J.E., et al. Bruton's tyrosine kinase is involved in miR-346-related regulation of IL-18 release by lipopolysaccharide-activated rheumatoid fibroblastlike synoviocytes. J Immunol 2009, 182:5088-5097.
61. Tsai N.P., Lin Y.L., Wie L.N. Micro-RNA mir346 targets the 5'UTR of RIP140 mRNA and up-regulates its protein expression. Biochem J 2009, 424:411-418.
62. O'Neill L.A. Boosting the brain's ability to block inflammation via microRNA-132. Immunity 2009, 31:854-855.
63. Lagos D., Pollara G., Henderson S., Gratrix F., Fabani M., Milne R.S., et al. miR-132 regulates antiviral innate immunity through suppression of the p300 transcriptional co-activator. Nat Cell Biol 2010, 12:513-519.
64. Cimmino A., Calin G.A., Fabbri M., Iorio M.V., Ferracin M., Shimizu M., et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005, 102:13944-13949.
65. Andersen D.C., Jensen C.H., Schneider M., Nossent A.Y., Eskildsen T., Hansen J.L., et al. MicroRNA-15a fine-tunes the level of Delta-like 1 homolog (DLK1) in proliferating 3 T3-L1 preadipocytes. Exp Cell Res 2010, 316:1681-1691.
66. Bhattacharya R., Nicoloso M., Arvizo R., Wang E., Cortez A., Rossi S., et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Res 2009, 69:9090-9095.
67. Persson M., Andrén Y., Mark J., Horlings H.M., Persson F., Stenman Recurrent G. fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci U S A 2009, 106:18740-18744.
68. Salerno E., Scaglione B.J., Coffman F.D., Brown B.D., Baccarini A., Fernandes H., et al. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Mol Cancer Ther 2009, 8:2684-2692.
69. Wang F., Fu X.D., Zhou Y., Zhang Y. Down-regulation of the cyclin E1 oncogene expression by microRNA-16-1 induces cell cycle arrest in human cancer cells. BMB Rep 2009, 42:725-730.
70. Xie S.Y., Li Y.J., Wang P.Y., Jiao F., Zhang S., Zhang W.J. miRNA-regulated expression of oncogenes and tumor suppressor genes in the cisplatin-inhibited growth of K562 cells. Oncol Rep 2010, 23:1693-1700.
71. Bartuma H., Nord K.H. G Macchia, M. Isaksson, J. Nilsson, H.A. Domanski, N. Mandahl, F. Mertens, Gene expression and single nucleotide polymorphism array analyses of spindle cell lipomas and conventional lipomas with 13q14 deletion. Genes Chromosomes Cancer 2011, 50:619-632.
72. Mosca L., Fabris S., Lionetti M., Todoerti K., Agnelli L., Morabito F., et al. Integrative genomics analyses reveal molecularly distinct subgroups of B-cell chronic lymphocytic leukemia patients with 13q14 deletion. Clin Cancer Res 2010, 16:5641-5653.
73. Lehmann S., Ogawa S., Raynaud S.D., Sanada M., Nannya Y., Ticchioni M., et al. Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia. Cancer 2008, 112:1296-1305.
74. Ouillette P., Erba H., Kujawski L., Kaminski M., Shedden K., Malek S.N. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14. Cancer Res 2008, 68:1012-1021.
75. Sethupathy P., Collins F.S. MicroRNA target site polymorphisms and human disease. Trends Genet 2008, 24:489-497.
76. Barenboim M., Zoltick B.J., Guo Y., Weinberger D.R. MicroSNiPer: a web tool for prediction of SNP effects on putative microRNA targets. Hum Mutat 2010, 31:1223-1232.
77. Witkos T.M., Koscianska E., Krzyzosiak W.J. Practical Aspects of microRNA Target Prediction. Curr Mol Med 2011, 11:93-109.
78. Lindow M. Prediction of targets for microRNAs. Methods Mol Biol 2011, 703:311-317.